April 25, 2017
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
| Attention: | Suzanne Hays, Assistant Director, Office and Healthcare and Insurance |
| Re: | Rich Pharmaceuticals, Inc. Form S-1 Registration Statement (Registration No. 333-217307), filed April 14, 2017 |
Acceleration Request
| Requested Date: | April 27, 2017 | |
| Requested Time: | 4:01 PM Eastern Time |
Ladies and Gentlemen:
Rich Pharmaceuticals,Inc. (the “Registrant”) hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the above-captioned Registration Statement on Form S-1 effective at the “Requested Date” and “Requested Time” set forth above, or as soon thereafter as practicable.
The Registrant hereby acknowledges that:
| • | should the Commission or the staff of the Commission, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; | ||
| • | the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and | ||
| • | the Registrant may not assert the staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. |
Thank you for your assistance.
| Sincerely, | ||
| RICH PHARMACUETICALS, INC. | ||
| By: | /s/ Ben Chang | |
Ben Chang Chief Executive Officer | ||